Board of Novartis India recommends Final Dividend
Board of Novartis India recommends Final Dividend of Rs.10 per share
capital market | Mumbai 12:01 IST | May 20, 2022
Novartis India reports standalone net loss of Rs 23.37 crore in the March 2022 quarter
Novartis India reports standalone net loss of Rs 23.37 crore in the March 2022 quarter sales decline 0.98% to Rs 98.32 crore
capital market | Mumbai 08:05 IST | May 20, 2022
Dr Reddy's Labs enters into exclusive sales and distribution agreement with Novartis India
Dr. Reddys will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium range and Methergine in India....
India Infoline News Service | Mumbai 09:45 IST | February 14, 2022
Novartis India to announce Quarterly Result
Novartis India to announce Quarterly Result on 10 February 2022
capital market | Mumbai 11:46 IST | December 31, 2021
Novartis India CFO resigns with effect from 31 December 2021
capital market | Mumbai 18:47 IST | December 20, 2021
Novartis India standalone net profit declines 6.65% in the September 2021 quarter
Novartis India standalone net profit declines 6.65% in the September 2021 quarter sales rise 9.03% to Rs 104.48 crore
capital market | Mumbai 16:12 IST | November 11, 2021
Novartis India to conduct board meeting
Novartis India to conduct board meeting on 11 November 2021
capital market | Mumbai 10:23 IST | October 01, 2021
Novartis India standalone net profit rises 43.05% in the June 2021 quarter
Novartis India standalone net profit rises 43.05% in the June 2021 quarter sales rise 6.11% to Rs 98.11 crore
capital market | Mumbai 15:49 IST | August 11, 2021
Bata India, Cadila Healthcare, Endurance Tech, New India Assurance, Antony Waste Handling Cell, Bajaj Electricals, HEG, India Cement, VIP Industries and Pidilite are among 300 companies slated to post their quarterly earnings....
India Infoline News Service | Mumbai 09:51 IST | August 11, 2021
Novartis India to discuss results
Novartis India to discuss results on 11 August 2021
capital market | Mumbai 09:27 IST | July 01, 2021
Novartis India to discuss results
Novartis India to discuss results novartis India to discuss results
capital market | Mumbai 00:00 IST | July 01, 2021
Novartis India standalone net profit rises 43% in Q4; stock ends ~6% lower
The board have approved recommended of final dividend of Rs10/- per Equity share of Rs5/- each for the year ended March 31, 2021, subject to the approval of the shareholders of the Company....
India Infoline News Service | Mumbai 16:18 IST | June 18, 2021
Novartis India to hold AGM on 27 August 2021
capital market | Mumbai 12:32 IST | June 18, 2021
Board of Novartis India recommends Final Dividend
Board of Novartis India recommends Final Dividend of Rs.10 per share
capital market | Mumbai 10:23 IST | June 18, 2021
Novartis India standalone net profit rises 43.07% in the March 2021 quarter
Novartis India standalone net profit rises 43.07% in the March 2021 quarter sales rise 5.97% to Rs 99.29 crore
capital market | Mumbai 16:49 IST | June 17, 2021
Novartis India Ltd leads gainers in A group
Novartis India Ltd leads gainers in A group fDC Ltd, Marksans Pharma Ltd, eClerx Services Ltd and Future Lifestyle Fashions Ltd are among the other gainers in the BSEs A group today, 14 June 2021.
capital market | Mumbai 12:00 IST | June 14, 2021
Novartis India revises board meeting date
Novartis India revises board meeting date on 17 June 2021
capital market | Mumbai 11:50 IST | May 12, 2021
Novartis India announces board meeting date
Novartis India announces board meeting date on 20 May 2021
capital market | Mumbai 10:44 IST | April 01, 2021
Novartis India reports standalone net loss of Rs 0.71 crore in the December 2020 quarter
Novartis India reports standalone net loss of Rs 0.71 crore in the December 2020 quarter sales decline 20.17% to Rs 93.77 crore
capital market | Mumbai 17:07 IST | February 11, 2021